Suppr超能文献

霍乱毒素无毒衍生物的构建及针对A亚基免疫反应的特性研究

Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.

作者信息

Fontana M R, Manetti R, Giannelli V, Magagnoli C, Marchini A, Olivieri R, Domenighini M, Rappuoli R, Pizza M

机构信息

IRIS, Biocine Immunobiological Research Institute Siena, Italy.

出版信息

Infect Immun. 1995 Jun;63(6):2356-60. doi: 10.1128/iai.63.6.2356-2360.1995.

Abstract

Using computer modelling, we have identified some of the residues of the A subunit of cholera toxin (CT) and heat-labile toxin that are involved in NAD binding, catalysis, and toxicity. Here we describe the site-directed mutagenesis of the CT gene and the construction of CT mutants. Nine mutations of the A subunit gene were generated. Six of them encoded proteins that were fully assembled in the AB5 structure and were nontoxic; these proteins were CT-D53 (Val-53-->Asp), CT-K63 (Ser-63-->Lys), CT-K97 (Val-97-->Lys), CT-K104 (Tyr-104-->Lys), CT-S106 (Pro-106-->Ser), and the double mutant CT-D53/K63 (Val-53-->Asp, Ser-63-->Lys). Two of the mutations encoded proteins that were assembled into the AB5 structure but were still toxic; these proteins were CT-H54 (Arg-54-->His) and CT-N107 (His-107-->Asn). Finally, one of the mutant proteins, CT-E114 (Ser-114-->Glu), was unable to assemble the A and the B subunits and produced only the B oligomer. The six nontoxic mutants were purified from the culture supernatants of recombinant Vibrio cholerae strains and further characterized. The CT-K63 mutant, which was the most efficient in assembly of the AB5 structure, was used to immunize rabbits and was shown to be able to induce neutralizing antibodies against both the A and B subunits. This molecule may be useful for the construction of improved vaccines against cholera.

摘要

通过计算机建模,我们已确定了霍乱毒素(CT)和不耐热毒素A亚基中一些参与烟酰胺腺嘌呤二核苷酸(NAD)结合、催化及毒性作用的残基。在此,我们描述了CT基因的定点诱变及CT突变体的构建。产生了9个A亚基基因的突变。其中6个编码的蛋白质能在AB5结构中完全组装且无毒;这些蛋白质分别是CT-D53(Val-53→Asp)、CT-K63(Ser-63→Lys)、CT-K97(Val-97→Lys)、CT-K104(Tyr-104→Lys)、CT-S106(Pro-106→Ser)以及双突变体CT-D53/K63(Val-53→Asp,Ser-63→Lys)。另外2个突变编码的蛋白质能组装成AB5结构但仍有毒性;这些蛋白质是CT-H54(Arg-54→His)和CT-N107(His-107→Asn)。最后,其中一个突变蛋白CT-E114(Ser-114→Glu)无法组装A亚基和B亚基,仅产生B寡聚体。从重组霍乱弧菌菌株的培养上清液中纯化出这6个无毒突变体并进行了进一步表征。CT-K63突变体在AB5结构组装方面效率最高,用其免疫兔子后发现能够诱导产生针对A亚基和B亚基的中和抗体。该分子可能有助于构建改良的霍乱疫苗。

相似文献

4
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.
Mol Microbiol. 1994 Oct;14(1):51-60. doi: 10.1111/j.1365-2958.1994.tb01266.x.
8
Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
FEMS Immunol Med Microbiol. 2009 Jul;56(2):179-84. doi: 10.1111/j.1574-695X.2009.00563.x. Epub 2009 May 5.
9
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
Infect Immun. 1997 Jul;65(7):2821-8. doi: 10.1128/iai.65.7.2821-2828.1997.
10
Construction and characterization of an auxotrophic ctxA mutant of O139 Vibrio cholerae.
Microb Pathog. 2010 Nov;49(5):211-6. doi: 10.1016/j.micpath.2010.06.001. Epub 2010 Jun 15.

引用本文的文献

1
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response.
J Clin Invest. 2019 Mar 1;129(3):1314-1328. doi: 10.1172/JCI122110. Epub 2019 Feb 18.
3
Progress towards a needle-free hepatitis B vaccine.
Pharm Res. 2011 May;28(5):986-1012. doi: 10.1007/s11095-010-0314-4. Epub 2010 Nov 19.
4
Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.
Immunol Invest. 2010;39(4-5):449-67. doi: 10.3109/08820130903563998.
5
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines.
Expert Rev Vaccines. 2009 Sep;8(9):1183-93. doi: 10.1586/erv.09.80.
8
Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.
Infect Immun. 2007 Jun;75(6):3150-9. doi: 10.1128/IAI.00581-06. Epub 2007 Mar 12.
10
NALT- versus Peyer's-patch-mediated mucosal immunity.
Nat Rev Immunol. 2004 Sep;4(9):699-710. doi: 10.1038/nri1439.

本文引用的文献

1
Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin.
J Mol Biol. 1993 Apr 5;230(3):890-918. doi: 10.1006/jmbi.1993.1209.
3
Epidemic cholera due to a novel strain of V. cholerae non-01--the beginning of a new pandemic?
J Infect. 1993 Sep;27(2):115-7. doi: 10.1016/0163-4453(93)94539-n.
4
Changes in human ecology and behavior in relation to the emergence of diarrheal diseases, including cholera.
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2390-4. doi: 10.1073/pnas.91.7.2390.
5
Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood.
Epidemiol Infect. 1994 Feb;112(1):1-11. doi: 10.1017/s0950268800057368.
6
Outbreak of Vibrio cholerae non-O1 in India and Bangladesh.
Lancet. 1993 May 22;341(8856):1346-7. doi: 10.1016/0140-6736(93)90855-b.
9
Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.
Protein Sci. 1994 Feb;3(2):166-75. doi: 10.1002/pro.5560030202.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验